Integrated Cultivation and Empowerment for Healthy Aging | Professor Zhang Xianzheng of Wuhan University Publishes in Advanced Materials, Revealing a Novel Strategy for Reprogramming Aging (IF: 26.8)
Release Date:
2025-12-09 16:13
Recently, Professor Xianzheng Zhang, School of Chemistry and Molecular Sciences, Wuhan University Team In the top-tier materials science journal “ Advanced Materials published a research paper titled “Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation.” This study proposes an innovative cancer treatment strategy that achieves tumor-specific senescence reprogramming by synergistically regulating two key targets—P16INK4a and PD-L1—thereby activating the immune system to combat tumors.
Paper Information
Title : Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation
Chinese Title Aging reprogramming unleashes tumor immune surveillance through coordinated gene regulation.
Journal : Advanced Materials
Impact factor : 26.8
Author's Affiliation : School of Chemistry and Molecular Sciences, Wuhan University
Publication Date : December 1, 2025
Digital Object Identifier :doi/10.1002/adma.202516597
Research Background
Cellular senescence can recruit immune cells via the senescence-associated secretory phenotype (SASP) for cancer therapy; however, its efficacy is often constrained by immune tolerance and the immunosuppressive tumor microenvironment (TME).
Research Content
The team has engineered a uPAR-targeted gene-delivery nanosystem (TEPP) that specifically induces SASP-mediated immune activation in tumor cells while simultaneously blocking PD-L1–mediated immunosuppression, thereby converting immunologically “cold” tumors into “hot” tumors. In multiple preclinical models, TEPP monotherapy markedly inhibits tumor growth and metastasis; when combined with immune checkpoint inhibitors, its antitumor efficacy is further enhanced.
Research Innovations
Collaborative Regulation Mechanism: Achieve tumor-specific senescence reprogramming by simultaneously modulating P16INK4a and PD-L1.
Delivery System Innovation: A tumor-targeted gene-delivery nanoplatform, TEPP, has been developed to enhance therapeutic specificity and reduce systemic toxicity.
Immune Microenvironment Remodeling: It not only activates the immune response but also reverses immunosuppression, thereby enhancing the efficacy of immunotherapy through a dual-pronged approach.
Significance and Prospects of the Study
This study not only unveils novel mechanisms underlying the coordinated regulation of aging and immunity, but also provides a critical technological platform and theoretical foundation for the development of combined strategies that integrate tumor-targeted delivery systems with immunotherapy. The research demonstrates that this platform exhibits robust modularity and scalability, enabling future integration with oncolytic viruses, attenuated Salmonella, and other agents to enhance targeting efficiency. Moreover, it can be combined with adoptive cell therapies—such as CAR-T and CAR-NK—to further bolster the durability and potency of anti-tumor immune responses.
Shanghai Hycells Biotechnology Co., Ltd. has provided a critical integrated cell-culture technology solution for this cutting-edge research. As an innovative biotech company dedicated to the development and delivery of primary-cell technologies, Hycells leverages its robust primary-cell resource bank and high-quality cell-culture and cryopreservation reagent systems to offer solid support for the construction of complex cellular models and functional validation in research. The outcomes of this collaboration serve as strong evidence that Hycells’s integrated, innovative culture technologies are effectively empowering basic scientific research and driving the translation of research findings into practical applications.
List of Integrated Cell Culture Products
|
Item number |
Product Name |
|
hPB3T-10C-NS |
Frozen hPB T Cells Separate Service (NS), 10 million |
|
HYS01002-kit |
Human T-Activator kit (4×10 7 cells) |
|
HYS-CF1000 |
Cell Feeder Bottom-Translucent Cell Culture Flask |
|
HYS01013 |
Serum-Free Cell Freezing Medium |
T-cell sample resources
Core function: Serving as the raw material and starting point for the entire process, it provides naïve T cells and forms the foundation for subsequent steps; the source is PBMCs or purified T cells from healthy donors or patients.
T-cell activation magnetic beads
Core function: Acts as the “initiator” of activation and proliferation signals by mimicking antigen-presenting cells through surface anti-CD3/CD28 antibodies, thereby delivering activation signals that trigger the critical transition of T cells from a quiescent state to activation and proliferation.
Cell Feeder Bottom-Translucent Cell Culture Flask
Core function: a “reactor” for cell expansion and maintenance, providing a long-term, stable in vitro culture environment for activated T cells.
Immune Cell Cryopreservation Solution
Core function: maintaining cell viability and function.
To ensure you receive efficient, precise pre-sales consultation and post-sales support, please scan the QR code below to activate our integrated, dedicated cell culture technical service.
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.